PDS Biotechnology Corp (PDSB)
3.82
+0.09
(+2.41%)
USD |
NASDAQ |
May 03, 16:00
3.825
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Max Drawdown (5Y): 99.86% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.86% |
March 31, 2024 | 99.86% |
February 29, 2024 | 99.86% |
January 31, 2024 | 99.86% |
December 31, 2023 | 99.86% |
November 30, 2023 | 99.86% |
October 31, 2023 | 99.86% |
September 30, 2023 | 99.86% |
August 31, 2023 | 99.86% |
July 31, 2023 | 99.86% |
June 30, 2023 | 99.86% |
May 31, 2023 | 99.86% |
April 30, 2023 | 99.86% |
March 31, 2023 | 99.86% |
February 28, 2023 | 99.86% |
January 31, 2023 | 99.86% |
December 31, 2022 | 99.86% |
November 30, 2022 | 99.86% |
October 31, 2022 | 99.86% |
September 30, 2022 | 99.86% |
August 31, 2022 | 99.86% |
July 31, 2022 | 99.86% |
June 30, 2022 | 99.86% |
May 31, 2022 | 99.86% |
April 30, 2022 | 99.86% |
Date | Value |
---|---|
March 31, 2022 | 99.86% |
February 28, 2022 | 99.86% |
January 31, 2022 | 99.86% |
December 31, 2021 | 99.86% |
November 30, 2021 | 99.86% |
October 31, 2021 | 99.86% |
September 30, 2021 | 99.86% |
August 31, 2021 | 99.86% |
July 31, 2021 | 99.86% |
June 30, 2021 | 99.86% |
May 31, 2021 | 99.86% |
April 30, 2021 | 99.86% |
March 31, 2021 | 99.86% |
February 28, 2021 | 99.86% |
January 31, 2021 | 99.86% |
December 31, 2020 | 99.86% |
November 30, 2020 | 99.86% |
October 31, 2020 | 99.86% |
September 30, 2020 | 99.86% |
August 31, 2020 | 99.86% |
July 31, 2020 | 99.86% |
June 30, 2020 | 99.86% |
May 31, 2020 | 99.86% |
April 30, 2020 | 99.86% |
March 31, 2020 | 99.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.84%
Minimum
May 2019
99.86%
Maximum
Apr 2020
99.76%
Average
99.86%
Median
Apr 2020
Max Drawdown (5Y) Benchmarks
Syros Pharmaceuticals Inc | 98.58% |
PAVmed Inc | 98.81% |
Altimmune Inc | 99.85% |
Regeneron Pharmaceuticals Inc | 53.84% |
iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -32.97 |
Beta (5Y) | 1.751 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 125.8% |
Historical Sharpe Ratio (5Y) | -0.107 |
Historical Sortino (5Y) | -0.2925 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.00% |